Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

TVRD Relative to the S&P 500

Seasonal Chart Analysis

Analysis of the Tvardi Therapeutics Inc (NASD:TVRD) seasonal charts above shows that a Buy Date of June 18 and a Sell Date of September 21 has resulted in a geometric average return of 5.74% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 40.39% per year.

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.

To download TVRD seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: TVRD